CVS Caremark (NYSE: CVS) announced today that it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.
"CVS Caremark Specialty Pharmacy is honored to receive this accreditation," said David Golding, Executive Vice President, CVS Caremark Specialty Pharmacy Services. "This accreditation demonstrates the company's longstanding commitment to providing outstanding services to our patients and clients in the complex, high touch arena of specialty pharmacy management."
CVS Caremark Specialty Pharmacy is focused on providing drug therapy management and dispensing services for patients requiring treatment with medications that are used to treat rare, chronic or genetic conditions. CVS Caremark provides specialty patients with support and counseling to help them manage their specialty medications to ensure appropriate and safe medication use and optimize positive outcomes. Services also include ongoing disease education and therapy counseling, benefits verification, coordination of care with multiple health care providers, comprehensive patient education and adherence management.
"CVS Caremark should be commended for meeting strict quality standards," said Alan P. Spielman, URAC President and CEO. "It is critically important for health care organizations to make a commitment to quality and accountability. URAC accreditation is a demonstration of that commitment."
URAC offers the only third-party, voluntary accreditation program of this scope for the pharmacy benefit management and prescription services industry. All standards were developed by URAC's Pharmacy Advisory Committee, which includes a wide range of stakeholders: employers, consumers, pharmacy consultants, health plans, retail pharmacy, pharmacy benefit management organizations, pharmacy professional organizations, labor, and large public purchasing groups.